Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate

Lignende værker

• Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
  af: Rymuza, Joanna, et al.
  Udgivet: (2018)
• Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves' Orbitopathy
  af: Miśkiewicz, Piotr, et al.
  Udgivet: (2018)
• Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome
  af: Maryla Pelewicz, et al.
  Udgivet: (2022-04-01)
• Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves’ Orbitopathy
  af: Miskiewicz, Piotr, et al.
  Udgivet: (2018)
• High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
  af: Miśkiewicz, P., et al.
  Udgivet: (2018)